BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32033892)

  • 1. Impact of Peer Review in Reducing Uncertainty in the Definition of the Lung Target Volume Among Trainee Oncologists.
    Mercieca S; Pan S; Belderbos J; Salem A; Tenant S; Aznar MC; Woolf D; Radhakrishna G; van Herk M
    Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):363-372. PubMed ID: 32033892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
    Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
    Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ProCaLung - Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium
    Charlier F; Descamps T; Lievens Y; Geets X; Remouchamps V; Lambrecht M; Moretti L
    Radiother Oncol; 2022 Feb; 167():57-64. PubMed ID: 34890738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
    Martin S; Johnson C; Brophy M; Palma DA; Barron JL; Beauchemin SS; Louie AV; Yu E; Yaremko B; Ahmad B; Rodrigues GB; Gaede S
    Acta Oncol; 2015 Mar; 54(3):322-32. PubMed ID: 25350526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp L; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Hart AA; Nowak PJ; van Herk M; Rasch CR
    Radiother Oncol; 2005 Nov; 77(2):182-90. PubMed ID: 16256231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of training and professional collaboration on the interobserver variation of lung cancer delineations: a multi-institutional study.
    Mercieca S; Belderbos JSA; van Baardwijk A; Delorme S; van Herk M
    Acta Oncol; 2019 Feb; 58(2):200-208. PubMed ID: 30375905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
    Spoelstra FO; Senan S; Le Péchoux C; Ishikura S; Casas F; Ball D; Price A; De Ruysscher D; van Sörnsen de Koste JR;
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1106-13. PubMed ID: 19560881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
    Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
    Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study.
    Lo AC; Liu M; Chan E; Lund C; Truong PT; Loewen S; Cao J; Schellenberg D; Carolan H; Berrang T; Wu J; Berthelet E; Olson R
    J Thorac Oncol; 2014 Apr; 9(4):527-33. PubMed ID: 24736076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
    Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
    Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
    Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
    Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.
    Giraud P; Elles S; Helfre S; De Rycke Y; Servois V; Carette MF; Alzieu C; Bondiau PY; Dubray B; Touboul E; Housset M; Rosenwald JC; Cosset JM
    Radiother Oncol; 2002 Jan; 62(1):27-36. PubMed ID: 11830310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.
    Aznar MC; Girinsky T; Berthelsen AK; Aleman B; Beijert M; Hutchings M; Lievens Y; Meijnders P; Meidahl Petersen P; Schut D; Maraldo MV; van der Maazen R; Specht L
    Acta Oncol; 2017 Apr; 56(4):608-613. PubMed ID: 28105886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of using motion compensated reconstructions for reducing inter-observer and intra-observer contouring variation for organs at risk in lung cancer patients.
    McWilliam A; Lee L; Harris M; Sheikh H; Pemberton L; Faivre-Finn C; van Herk M
    Radiother Oncol; 2018 Feb; 126(2):333-338. PubMed ID: 29221648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
    Greco C; Rosenzweig K; Cascini GL; Tamburrini O
    Lung Cancer; 2007 Aug; 57(2):125-34. PubMed ID: 17478008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The delineation of target volumes for radiotherapy of lung cancer patients.
    Vorwerk H; Beckmann G; Bremer M; Degen M; Dietl B; Fietkau R; Gsänger T; Hermann RM; Alfred Herrmann MK; Höller U; van Kampen M; Körber W; Maier B; Martin T; Metz M; Richter R; Siekmeyer B; Steder M; Wagner D; Hess CF; Weiss E; Christiansen H
    Radiother Oncol; 2009 Jun; 91(3):455-60. PubMed ID: 19339069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peer Review of Radiotherapy Planning: Quantifying Outcomes and a Proposal for Prospective Data Collection.
    Mackenzie J; Graham G; Olivotto IA
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e192-e198. PubMed ID: 27633327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation.
    Dionisi F; Di Rito A; Errico A; Iaccarino G; Farneti A; D'Urso P; Nardangeli A; Bambace S; D'Onofrio I; D'Angelo E; De Felice F; Fanetti G; Belgioia L; Alterio D; Orlandi E; Merlotti A; Musio D; Sanguineti G
    Radiol Med; 2023 Mar; 128(3):362-371. PubMed ID: 36877421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol.
    Konert T; Vogel WV; Everitt S; MacManus MP; Thorwarth D; Fidarova E; Paez D; Sonke JJ; Hanna GG
    Radiother Oncol; 2016 Oct; 121(1):39-45. PubMed ID: 27663950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.